β ViewAdvancedBusiness & Law βΊ Corporate Finance & Governance
Pharmaceutical Lobbying Group PhRMA Appoints Former House Leader Eric Cantor as CEO
The Pharmaceutical Research and Manufacturers of America (PhRMA) has named former House Majority Leader Eric Cantor as its new president and CEO. Cantor, who transitions from a senior role at Moelis & Company, will take the helm of the powerful trade group this November to navigate an increasingly complex regulatory and political landscape.
2mΒ·π 0
β ExplanationFoundationsTax Strategy βΊ Tax Planning
Why the Tax Code Is the Way It Is
The U.S. tax code is 70,000+ pages of exceptions, carve-outs, and special rules. Here's why it's so complicated β and who benefits from the complexity.
4mΒ·π 0
β Explanationπ StandardAdvancedGovernment & Fiscal Policy βΊ Fiscal Policy
Lobbying Cases That Changed Policy β When Political Influence Moved History
Abstract discussions of lobbying become concrete when examining specific cases where organized interest groups changed the direction of policy. Here are the most consequential.
3mΒ·π 0
β Explanationβ‘ Quick ReadAdvancedGovernment & Fiscal Policy βΊ Fiscal Policy
What Is Lobbying β How Political Influence Works
Lobbying is one of the most misunderstood activities in American politics. Hereβs a clear-eyed explanation of what lobbying is, who does it, and how it actually works.
2mΒ·π 0
β Explanationπ StandardAdvancedGovernment & Fiscal Policy βΊ Fiscal Policy
The Economic Effects of Lobbying β What Political Influence Costs Society
Lobbying is legal and constitutionally protected. But its economic effects β on market competition, regulation, innovation, and the distribution of economic gains β are significant and largely underappreciated.
3mΒ·π 4
β Explanationπ StandardAdvancedGovernment & Fiscal Policy βΊ Fiscal Policy
Lobbying Around the World β How Different Countries Manage Political Influence
Lobbying exists in every political system, but the rules, transparency, and outcomes differ dramatically. A global comparison of how countries manage the relationship between money and policy.
3mΒ·π 0
β Explanationπ StandardAdvancedGeopolitics & Defense βΊ Defense Economics
The Military-Industrial Complex β Its Economic Footprint and Political Power
Eisenhower warned about the military-industrial complex in 1961. Here's what it is, how it works economically, and why it's proven so difficult to reform.
3mΒ·π 0
β Viewπ StandardUnderstandingGeopolitics & Defense βΊ Defense Economics
The Permanent War Economy
The U.S. military-industrial complex has become structurally self-sustaining β its size and cost justified by threats it sometimes helps create, sustained by a political economy that resists reduction regardless of the strategic environment.
4mΒ·π 3
β Explanationβ‘ Quick ReadAdvancedGovernment & Fiscal Policy βΊ Fiscal Policy
The Structural Barriers to Healthcare Reform
Every serious healthcare reform proposal in the U.S. has failed or been diluted beyond recognition. Here's why β and what the structural barriers actually are.
2mΒ·π 1
β Viewβ‘ Quick ReadUnderstandingGovernment & Fiscal Policy βΊ Fiscal Policy
When Good Ideas Fail β The Gap Between Policy Logic and Political Reality
History is littered with policy proposals that were logically sound, broadly beneficial, and politically impossible. Here's why good ideas so reliably fail in democratic systems.
2mΒ·π 1
β Explanationβ‘ Quick ReadAdvancedGovernment & Fiscal Policy βΊ Fiscal Policy
The Incumbent Advantage β How Existing Systems Protect Themselves
Incumbent industries, institutions, and interest groups have structural advantages in preserving the status quo. Here's how those advantages work β and why they're so hard to overcome.
3mΒ·π 0